Insecticides Intrinsic Value
INSECTICID • Chemicals
Current Stock Price
₹622.25
Primary Intrinsic Value
₹974.88
Market Cap
₹1805 Cr
+13.7%
Upside
Median Value
₹707.31
Value Range
₹301 - ₹1245
Assessment
Trading Below Median Value
Safety Margin
12.0%
INSECTICID Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹974.88 | ₹779.90 - ₹1169.86 | +56.7% | EPS: ₹81.24, Sector P/E: 12x |
| Book Value Method | asset | ₹374.14 | ₹336.73 - ₹411.55 | -39.9% | Book Value/Share: ₹374.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹707.31 | ₹636.58 - ₹778.04 | +13.7% | Revenue/Share: ₹884.14, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹761.38 | ₹685.24 - ₹837.52 | +22.4% | EBITDA: ₹368.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹300.92 | ₹240.74 - ₹361.10 | -51.6% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹519.94 | ₹467.95 - ₹571.93 | -16.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹669.42 | ₹602.48 - ₹736.36 | +7.6% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1244.50 | ₹1120.05 - ₹1368.95 | +100.0% | ROE: 21.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹748.28 | ₹673.45 - ₹823.11 | +20.3% | EPS: ₹81.24, BVPS: ₹374.14 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
INSECTICID Intrinsic Value Analysis
What is the intrinsic value of INSECTICID?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Insecticides (INSECTICID) is ₹707.31 (median value). With the current market price of ₹622.25, this represents a +13.7% variance from our estimated fair value.
The valuation range spans from ₹300.92 to ₹1244.50, indicating ₹300.92 - ₹1244.50.
Is INSECTICID undervalued or overvalued?
Based on our multi-method analysis, Insecticides (INSECTICID) appears to be trading below median value by approximately 13.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 39.58 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 21.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Insecticides
Additional stock information and data for INSECTICID
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹94 Cr | ₹75 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹187 Cr | ₹164 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-11 Cr | ₹-54 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹135 Cr | ₹135 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹155 Cr | ₹99 Cr | Positive Free Cash Flow | 8/10 |